MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
Nuvation Bio Inc.

NUVB

#3994
Nuvation Bio Inc.
5.92
+5.71%
Sector:
Base:
Profit Currency:
Daily Range
5.79
5.92
Year Range
1.54
9.75
Daily Change
+5.71%
Monthly Change
+5.53%
6 month change
+98.66%
Year Change
+203.59%
Previous Close
5.60
Open
5.79
Bid
Ask
Low
5.79
High
5.92
Volume
1 640
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. NUVB
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Value 20202021202220232024 TTM

News

Zacks Zacks
RGNX NUVB
2 days ago, 15:00
Regenxbio (RGNX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Seeking Alpha Seeking Alpha
GOOGL META ET LAD ABG
2026.02.23
Tracking David Abrams' Abrams Capital Management Portfolio - Q4 2025 Update
Investing Investing
NUVB
2026.02.09
Nuvation Bio expands SIGMA trial to phase 3 for IDH1-mutant glioma
Investing Investing
NUVB
2026.02.04
Nuvation Bio stock maintains Buy rating at B.Riley on Ibtrozi sales momentum
Seeking Alpha Seeking Alpha
NUVB
2026.02.02
Nuvation Bio: Rollout Data Of Ibtrozi Support A Modest Buy (NYSE:NUVB)
Investing Investing
NUVB
2026.01.27
Truist Securities raises Nuvation Bio stock price target to $13 on Ibtrozi uptake
Investing Investing
NUVB
2026.01.15
Jones Trading raises Nuvation Bio stock price target to $12 on safusidenib study
Zacks Zacks
NUVB
2026.01.13
Down 24% in 4 Weeks, Here's Why Nuvation Bio (NUVB) Looks Ripe for a Turnaround
Investing Investing
NUVB
2026.01.13
Nuvation Bio stock price target lowered to $17 at H.C. Wainwright
Investing Investing
NUVB
2026.01.13
Nuvation Bio stock rating reiterated at Market Outperform by Citizens
Investing Investing
C DIS ISRG MA WMT
2026.01.12
Alibaba, American Express among market cap stock movers on Monday
Investing Investing
NUVB
2026.01.12
Eisai to license taletrectinib for ROS1+ lung cancer across Europe, Asia

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Market
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
MQL5 Channels
Economic Calendar
Disclaimer and Risk Disclosure Terms of Use Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd